25 May 2013
Keywords: celltech, sells, biologics, unit, uk, selling, its
Article | 17 June 1996
Celltech of the UK is selling its only profitable business unit,
Celltech Biologics, to Alusuisse-Lonza of Switzerland. The Swiss company
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
29 April 1996
24 May 2013
© 2013 thepharmaletter.com